Riskpilot← Back to searchSign inGet full accessPhiBac Labs AB
ABActiveOrg 5591333009Gäddvägen 8 ABusiness and other management consultancy activities · NACE 7020Est. 20170 employees
Revenue 2024
SEK 0
EBITDA margin
—
-33% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -2K
-33% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | -33% |
| Net profit | SEK -2K | -33% |
| Total assets | SEK 46K | -4% |
| Equity | SEK 46K | -4% |
| Employees | 0 | — |
Legal name
PhiBac Labs AB
Org number
5591333009
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
10 november 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva managementkonsultverksamhet och projekt- och verksamhetsutveckling samt därmed förenlig verksamhet. Däribland skall bolaget bedriva enskild rådgivning i företagsledningsfrågor, rådgivning och genomförandestöd i företagsledningsfrågor, utvärdering och utveckling av strategier och -lösningar, marknads- och försäljningsanalys samt genomförandestöd, personalrekrytering, så kallad management for hire, rekryteringsverksamhet så kallad executive search och selection, investering och aktivt ägande i existerande och nya företag samt därmed förenlig verksamhet. Bolaget skall även jobba med förvaltning av värdepapper samt äga och förvalta fastigheter och bedriva därmed förenlig verksamhet.
Address
Gäddvägen 8 A
Email
backman.philip@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 | −2 | −1 | −2 | −2 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −1 | −2 | −1 | −2 | −2 |
| Net financials | — | — | — | — | — |
| Profit before tax | −1 | −2 | −1 | −2 | −2 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −1 | −2 | −1 | −2 | −2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 103 | 51 | 49 | 48 | 46 |
| Equity | 103 | 51 | 49 | 48 | 46 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 0 | 0 | — | — | — |
| Total debt | — | — | — | — | — |
EBITDA margin
-205500.0%
This company
15.8%
Market median
-1300733% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-4.5%
This company
18.4%
Market median
-124% vs market
20202024
Net profit margin
-205500.0%
This company
8.1%
Market median
-2537137% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PhiBac Labs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Lennart Bäckman | Deputy Board Member | 0 companies |
| Bertil Philip Ingemar Bäckman | Board of Directors | 0 companies |